Loading…

Glutathione-Triggered “Off–On” Release of Anticancer Drugs from Dendrimer-Encapsulated Gold Nanoparticles

Polymeric nanoparticles that can stably load anticancer drugs and release them in response to a specific trigger such as glutathione are of great interest in cancer therapy. In the present study, dendrimer-encapsulated gold nanoparticles (DEGNPs) were synthesized and used as carriers of thiolated an...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Chemical Society 2013-07, Vol.135 (26), p.9805-9810
Main Authors: Wang, Xinyu, Cai, Xiaopan, Hu, Jingjing, Shao, Naimin, Wang, Fei, Zhang, Qiang, Xiao, Jianru, Cheng, Yiyun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a315t-572fe5940dacbbea60524d58c50a5e1dda0728765e79b0c90a7e940f205558c63
cites cdi_FETCH-LOGICAL-a315t-572fe5940dacbbea60524d58c50a5e1dda0728765e79b0c90a7e940f205558c63
container_end_page 9810
container_issue 26
container_start_page 9805
container_title Journal of the American Chemical Society
container_volume 135
creator Wang, Xinyu
Cai, Xiaopan
Hu, Jingjing
Shao, Naimin
Wang, Fei
Zhang, Qiang
Xiao, Jianru
Cheng, Yiyun
description Polymeric nanoparticles that can stably load anticancer drugs and release them in response to a specific trigger such as glutathione are of great interest in cancer therapy. In the present study, dendrimer-encapsulated gold nanoparticles (DEGNPs) were synthesized and used as carriers of thiolated anticancer drugs. Thiol-containing drugs such as captopril and 6-mercaptopurine loaded within DEGNPs showed an “Off–On” release behavior in the presence of thiol-reducing agents such as glutathione and dithiothreitol. Thiolated doxorubicin and cisplatin, loaded within the nanoparticle, showed much reduced cytotoxicity as compared to the free anticancer compounds. The toxicity of drug-loaded DEGNPs can be enhanced by improving the intracellular glutathione. Glutathione-triggered release of thiolated doxorubicin within cancer cells is further confirmed by flow cytometry and confocal laser scan microscopy studies. In addition, DEGNPs showed excellent biocompatibility on several cell lines. This study provides a new insight into biomedical applications of dendrimers and dendrimer-encapsulated nanoparticles.
doi_str_mv 10.1021/ja402903h
format article
fullrecord <record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_ja402903h</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>c552741743</sourcerecordid><originalsourceid>FETCH-LOGICAL-a315t-572fe5940dacbbea60524d58c50a5e1dda0728765e79b0c90a7e940f205558c63</originalsourceid><addsrcrecordid>eNpt0L9OwzAQBnALgWgpDLwAysLAEDg7cf6MVVsKUkUlVObo4pzbVGlS2cnA1ndghZfrk2BU6MR0Oul3n04fY9cc7jkI_rDGEEQKweqE9bkU4EsuolPWBwDhx0kU9NiFtWu3hiLh56wngjhJYx70WTOtuhbbVdnU5C9MuVySocLb7z7nWu93H_N6v_vyXqkitOQ12hvWbamwVmS8semW1tOm2XhjqgtTbsj4k1rh1nYVti5m2lSF94J1s0Xjziqyl-xMY2Xp6ncO2NvjZDF68mfz6fNoOPMx4LL1ZSw0yTSEAlWeE0YgRVjIRElASbwoEGKRxJGkOM1BpYAxOa0FSOlUFAzY3SFXmcZaQzrbuv_QvGccsp_SsmNpzt4c7LbLN1Qc5V9LDtweACqbrZvO1O71f4K-ASKpdus</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Glutathione-Triggered “Off–On” Release of Anticancer Drugs from Dendrimer-Encapsulated Gold Nanoparticles</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Wang, Xinyu ; Cai, Xiaopan ; Hu, Jingjing ; Shao, Naimin ; Wang, Fei ; Zhang, Qiang ; Xiao, Jianru ; Cheng, Yiyun</creator><creatorcontrib>Wang, Xinyu ; Cai, Xiaopan ; Hu, Jingjing ; Shao, Naimin ; Wang, Fei ; Zhang, Qiang ; Xiao, Jianru ; Cheng, Yiyun</creatorcontrib><description>Polymeric nanoparticles that can stably load anticancer drugs and release them in response to a specific trigger such as glutathione are of great interest in cancer therapy. In the present study, dendrimer-encapsulated gold nanoparticles (DEGNPs) were synthesized and used as carriers of thiolated anticancer drugs. Thiol-containing drugs such as captopril and 6-mercaptopurine loaded within DEGNPs showed an “Off–On” release behavior in the presence of thiol-reducing agents such as glutathione and dithiothreitol. Thiolated doxorubicin and cisplatin, loaded within the nanoparticle, showed much reduced cytotoxicity as compared to the free anticancer compounds. The toxicity of drug-loaded DEGNPs can be enhanced by improving the intracellular glutathione. Glutathione-triggered release of thiolated doxorubicin within cancer cells is further confirmed by flow cytometry and confocal laser scan microscopy studies. In addition, DEGNPs showed excellent biocompatibility on several cell lines. This study provides a new insight into biomedical applications of dendrimers and dendrimer-encapsulated nanoparticles.</description><identifier>ISSN: 0002-7863</identifier><identifier>EISSN: 1520-5126</identifier><identifier>DOI: 10.1021/ja402903h</identifier><identifier>PMID: 23789713</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Cell Survival - drug effects ; Dendrimers - chemistry ; Dose-Response Relationship, Drug ; Doxorubicin - chemistry ; Doxorubicin - pharmacology ; Drug Carriers - chemistry ; Drug Screening Assays, Antitumor ; Glutathione - chemistry ; Gold - chemistry ; HeLa Cells ; Humans ; Metal Nanoparticles - chemistry ; Molecular Structure ; Structure-Activity Relationship ; Sulfhydryl Compounds - chemistry</subject><ispartof>Journal of the American Chemical Society, 2013-07, Vol.135 (26), p.9805-9810</ispartof><rights>Copyright © 2013 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a315t-572fe5940dacbbea60524d58c50a5e1dda0728765e79b0c90a7e940f205558c63</citedby><cites>FETCH-LOGICAL-a315t-572fe5940dacbbea60524d58c50a5e1dda0728765e79b0c90a7e940f205558c63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23789713$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Xinyu</creatorcontrib><creatorcontrib>Cai, Xiaopan</creatorcontrib><creatorcontrib>Hu, Jingjing</creatorcontrib><creatorcontrib>Shao, Naimin</creatorcontrib><creatorcontrib>Wang, Fei</creatorcontrib><creatorcontrib>Zhang, Qiang</creatorcontrib><creatorcontrib>Xiao, Jianru</creatorcontrib><creatorcontrib>Cheng, Yiyun</creatorcontrib><title>Glutathione-Triggered “Off–On” Release of Anticancer Drugs from Dendrimer-Encapsulated Gold Nanoparticles</title><title>Journal of the American Chemical Society</title><addtitle>J. Am. Chem. Soc</addtitle><description>Polymeric nanoparticles that can stably load anticancer drugs and release them in response to a specific trigger such as glutathione are of great interest in cancer therapy. In the present study, dendrimer-encapsulated gold nanoparticles (DEGNPs) were synthesized and used as carriers of thiolated anticancer drugs. Thiol-containing drugs such as captopril and 6-mercaptopurine loaded within DEGNPs showed an “Off–On” release behavior in the presence of thiol-reducing agents such as glutathione and dithiothreitol. Thiolated doxorubicin and cisplatin, loaded within the nanoparticle, showed much reduced cytotoxicity as compared to the free anticancer compounds. The toxicity of drug-loaded DEGNPs can be enhanced by improving the intracellular glutathione. Glutathione-triggered release of thiolated doxorubicin within cancer cells is further confirmed by flow cytometry and confocal laser scan microscopy studies. In addition, DEGNPs showed excellent biocompatibility on several cell lines. This study provides a new insight into biomedical applications of dendrimers and dendrimer-encapsulated nanoparticles.</description><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Cell Survival - drug effects</subject><subject>Dendrimers - chemistry</subject><subject>Dose-Response Relationship, Drug</subject><subject>Doxorubicin - chemistry</subject><subject>Doxorubicin - pharmacology</subject><subject>Drug Carriers - chemistry</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Glutathione - chemistry</subject><subject>Gold - chemistry</subject><subject>HeLa Cells</subject><subject>Humans</subject><subject>Metal Nanoparticles - chemistry</subject><subject>Molecular Structure</subject><subject>Structure-Activity Relationship</subject><subject>Sulfhydryl Compounds - chemistry</subject><issn>0002-7863</issn><issn>1520-5126</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpt0L9OwzAQBnALgWgpDLwAysLAEDg7cf6MVVsKUkUlVObo4pzbVGlS2cnA1ndghZfrk2BU6MR0Oul3n04fY9cc7jkI_rDGEEQKweqE9bkU4EsuolPWBwDhx0kU9NiFtWu3hiLh56wngjhJYx70WTOtuhbbVdnU5C9MuVySocLb7z7nWu93H_N6v_vyXqkitOQ12hvWbamwVmS8semW1tOm2XhjqgtTbsj4k1rh1nYVti5m2lSF94J1s0Xjziqyl-xMY2Xp6ncO2NvjZDF68mfz6fNoOPMx4LL1ZSw0yTSEAlWeE0YgRVjIRElASbwoEGKRxJGkOM1BpYAxOa0FSOlUFAzY3SFXmcZaQzrbuv_QvGccsp_SsmNpzt4c7LbLN1Qc5V9LDtweACqbrZvO1O71f4K-ASKpdus</recordid><startdate>20130703</startdate><enddate>20130703</enddate><creator>Wang, Xinyu</creator><creator>Cai, Xiaopan</creator><creator>Hu, Jingjing</creator><creator>Shao, Naimin</creator><creator>Wang, Fei</creator><creator>Zhang, Qiang</creator><creator>Xiao, Jianru</creator><creator>Cheng, Yiyun</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20130703</creationdate><title>Glutathione-Triggered “Off–On” Release of Anticancer Drugs from Dendrimer-Encapsulated Gold Nanoparticles</title><author>Wang, Xinyu ; Cai, Xiaopan ; Hu, Jingjing ; Shao, Naimin ; Wang, Fei ; Zhang, Qiang ; Xiao, Jianru ; Cheng, Yiyun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a315t-572fe5940dacbbea60524d58c50a5e1dda0728765e79b0c90a7e940f205558c63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Cell Survival - drug effects</topic><topic>Dendrimers - chemistry</topic><topic>Dose-Response Relationship, Drug</topic><topic>Doxorubicin - chemistry</topic><topic>Doxorubicin - pharmacology</topic><topic>Drug Carriers - chemistry</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Glutathione - chemistry</topic><topic>Gold - chemistry</topic><topic>HeLa Cells</topic><topic>Humans</topic><topic>Metal Nanoparticles - chemistry</topic><topic>Molecular Structure</topic><topic>Structure-Activity Relationship</topic><topic>Sulfhydryl Compounds - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Xinyu</creatorcontrib><creatorcontrib>Cai, Xiaopan</creatorcontrib><creatorcontrib>Hu, Jingjing</creatorcontrib><creatorcontrib>Shao, Naimin</creatorcontrib><creatorcontrib>Wang, Fei</creatorcontrib><creatorcontrib>Zhang, Qiang</creatorcontrib><creatorcontrib>Xiao, Jianru</creatorcontrib><creatorcontrib>Cheng, Yiyun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of the American Chemical Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Xinyu</au><au>Cai, Xiaopan</au><au>Hu, Jingjing</au><au>Shao, Naimin</au><au>Wang, Fei</au><au>Zhang, Qiang</au><au>Xiao, Jianru</au><au>Cheng, Yiyun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glutathione-Triggered “Off–On” Release of Anticancer Drugs from Dendrimer-Encapsulated Gold Nanoparticles</atitle><jtitle>Journal of the American Chemical Society</jtitle><addtitle>J. Am. Chem. Soc</addtitle><date>2013-07-03</date><risdate>2013</risdate><volume>135</volume><issue>26</issue><spage>9805</spage><epage>9810</epage><pages>9805-9810</pages><issn>0002-7863</issn><eissn>1520-5126</eissn><abstract>Polymeric nanoparticles that can stably load anticancer drugs and release them in response to a specific trigger such as glutathione are of great interest in cancer therapy. In the present study, dendrimer-encapsulated gold nanoparticles (DEGNPs) were synthesized and used as carriers of thiolated anticancer drugs. Thiol-containing drugs such as captopril and 6-mercaptopurine loaded within DEGNPs showed an “Off–On” release behavior in the presence of thiol-reducing agents such as glutathione and dithiothreitol. Thiolated doxorubicin and cisplatin, loaded within the nanoparticle, showed much reduced cytotoxicity as compared to the free anticancer compounds. The toxicity of drug-loaded DEGNPs can be enhanced by improving the intracellular glutathione. Glutathione-triggered release of thiolated doxorubicin within cancer cells is further confirmed by flow cytometry and confocal laser scan microscopy studies. In addition, DEGNPs showed excellent biocompatibility on several cell lines. This study provides a new insight into biomedical applications of dendrimers and dendrimer-encapsulated nanoparticles.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>23789713</pmid><doi>10.1021/ja402903h</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-7863
ispartof Journal of the American Chemical Society, 2013-07, Vol.135 (26), p.9805-9810
issn 0002-7863
1520-5126
language eng
recordid cdi_crossref_primary_10_1021_ja402903h
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Cell Survival - drug effects
Dendrimers - chemistry
Dose-Response Relationship, Drug
Doxorubicin - chemistry
Doxorubicin - pharmacology
Drug Carriers - chemistry
Drug Screening Assays, Antitumor
Glutathione - chemistry
Gold - chemistry
HeLa Cells
Humans
Metal Nanoparticles - chemistry
Molecular Structure
Structure-Activity Relationship
Sulfhydryl Compounds - chemistry
title Glutathione-Triggered “Off–On” Release of Anticancer Drugs from Dendrimer-Encapsulated Gold Nanoparticles
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T14%3A09%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glutathione-Triggered%20%E2%80%9COff%E2%80%93On%E2%80%9D%20Release%20of%20Anticancer%20Drugs%20from%20Dendrimer-Encapsulated%20Gold%20Nanoparticles&rft.jtitle=Journal%20of%20the%20American%20Chemical%20Society&rft.au=Wang,%20Xinyu&rft.date=2013-07-03&rft.volume=135&rft.issue=26&rft.spage=9805&rft.epage=9810&rft.pages=9805-9810&rft.issn=0002-7863&rft.eissn=1520-5126&rft_id=info:doi/10.1021/ja402903h&rft_dat=%3Cacs_cross%3Ec552741743%3C/acs_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a315t-572fe5940dacbbea60524d58c50a5e1dda0728765e79b0c90a7e940f205558c63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/23789713&rfr_iscdi=true